Economic Times•Business•19 ఆగ
Moderna Shares Soar 135 In A Day After Cancer Vaccine Succeeds In Late Stage Trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly